An internally controlled peripheral biomarker for Alzheimer’s disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin
Author of publication
Tapan K. Khan and Daniel L. Alkon
Date of publication
29/08/2006
Download
RW-Admin
Association of Cognitive Function Trajectories in Centenarians With Postmortem Neuropathology, Physical Health, and Other Risk Factors for Cognitive Decline
Prev post
PKC Deficits in Alzheimer’s Disease Brains and Skin Fibroblasts
Next post
Search for:
Recent Posts
Neurodiagnostics, LLC New Alzheimer’s Assay Granted Breakthrough Device Designation By U.S. Food And Drug Administration
Alzheimer’s Disease: A Giving Smarter Guide To Accelerate Development Of New Therapies
Alzheimer’s Association 2019 Facts And Figures Report
Alzheimer’s Association 2018 Facts And Figures Report
Sciencedaily Cites Elderly Discovered With Superior Memory And Alzheimer’s Pathology
Recent Comments
Archives
October 2019
September 2019
December 2018
November 2018
Categories
Uncategorized
Meta
Log in
Entries feed
Comments feed
WordPress.org
Input your search keywords and press Enter.
Recent Comments